Sri Lanka, April 22 -- The Sri Lankan pharmaceutical industry will be able to reduce around 30% of total pharma imports by 2030 opined senior members of the Sri Lanka Chamber of the Pharmaceutical Industry. (SLCPI).

They said that one of the main reasons for this is the buyback guarantee that was presented by the government for pharma manufacturers. "This prompted many local companies to invest in Sri Lanka and today there is a very strong local supply in the market. Soon pharma exports too will take place."

Today over 15% of the market is made of local manufacturing, a significant increase within the last 10 years. "Local manufacturing capacity is expected to increase to approximately 30% by 2030. The private pharmaceutical industry ge...